Psychedelic-assisted therapy: ‘the beginning’ of a health benefits trend?
Employee interest in psychedelics for mental health treatment is growing, which experts say may drive interest among employers, eager to tackle the $3.7 trillion in annual costs for untreated mental illness.
The post Psychedelic-assisted therapy: ‘the beginning’ of a health benefits trend? appeared first on HR Executive.